Wealthcare Capital Partners’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Sell
5,276
-122
-2% -$6.4K 0.11% 140
2026
Q1
$284K Buy
5,398
+287
+6% +$14.6K 0.13% 125
2025
Q4
$240K Sell
5,111
-12
-0.2% -$562 0.11% 131
2025
Q3
$240K Buy
5,123
+83
+2% +$4.01K 0.11% 132
2025
Q2
$246K Buy
5,040
+65
+1% +$3.15K 0.12% 129
2025
Q1
$258K Buy
4,975
+16
+0.3% +$821 0.13% 110
2024
Q4
$239K Buy
+4,959
New +$238K 0.12% 108

Other funds holding AMLP

Wealthcare Capital Partners's AMLP Position: Q2 2026 in Review

Wealthcare Capital Partners reduced its Alerian MLP ETF (AMLP) stake by 2.3% in Q2 2026, selling an estimated $6.4K and leaving 5,276 shares worth $274K. The position accounts for 0.11% of the portfolio, ranked #140.

Wealthcare Capital Partners first reported a position in AMLP in Q4 2024 and has held it in 7 quarters since. The position peaked at $284K in Q1 2026. 378 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.

  • Wealthcare Capital Partners held 5,276 shares of Alerian MLP ETF worth $274K as of Q2 2026.
  • Wealthcare Capital Partners sold 122 Alerian MLP ETF shares in Q2 2026, an estimated $6.4K.
  • Alerian MLP ETF made up 0.11% of Wealthcare Capital Partners's portfolio in Q2 2026, its #140 holding.
  • Wealthcare Capital Partners first reported a position in Alerian MLP ETF in Q4 2024 and has held it in 7 quarters since.
  • Wealthcare Capital Partners's Alerian MLP ETF position peaked at $284K in Q1 2026.
  • 378 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.